Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The Agreement was effectuated by the Company's purchase of the twenty-five percent (25%) stake in a joint venture from Cannabis Science, Inc. (NASDAQ OTC: CBIS)
It looks like XCHC has 25% of the joint venture, while CBIS with the third party owns 75%. Is that right?
what does the 25% mean in the X-PR?
the more the cry, the higher CBIS
A solid news?
It is the time for CBIS to run according to the rule of this board: more and more n* post.
So I ask those persons post more N* posts on CBIS! Please and Please!
GO CBIS!!!
both can gain money. Do you like big pharm control all thing for cancer treatment
please refer to coca cola
You mean $1.0
GO CBIS!
CBIS always has you
no problem, just a truth as you claim.
We will see a new CBIS run!
GO CBIS!
Agree! GO CBIS!
You are never tired for that?
I am tired with your post on this board!
GO CBIS!
Around 10% exchange hand!
Fifth volume just less than other fours in the run of $0.24!
GO CBIS!
CBIS running pattern:
just take a look at CBIS chart from Oct 2010, there is always a shake between 0.08 and 0.10 just before the big runs ($0.27 and $0.24).
Today, the market is very strange, isn`t it?
CBIS should release a PR this week. SO the target is still around $0.15~0.20 within this week, imo.
institutions/MMs need more shares for mmj sector including CBIS
you mean: $0.05*24=$1.2
GO CBIS
the next PR will be the abstract submission, which includes the patients results. Just wait for a very few days!
GO CBIS
Target price: ~$0.10 Tuesday, if any solid PR out, CBIS will touch $0.25 again, IMO.
GO CBIS
I remember you told us: CBIS will touch 100cents. Is that right?
GO CBIS
You mean CBIS will touch 100 cents? Really, that is great!
GO CBIS!!!
There will be at least four PRs in the very next future according to the most recent PR:
1. Abstract submissions to conferences
2. Appointment of the expertise of incoming officers
3. The development of protocols for submission to NIH
4. European clinical research programs
Possible 5: FDA application
The third one looks like a grant application, and what does the fourth one mean?
The possible one is a bomb, isn`t it? Where is the divy? What is the next week target: $0.25? $0.28? $0.70? TBD?......
IMO
GO CBIS
Could you please say some reasonable thing as a man? Many thanks!
GO CBIS!
Will be over 50 million?
Just wait for the power hour!
What?
Breaking news?
GO CBIS!
I think it is too early. Another PR should be released next Tuesday, imo. If the next PR is solid one, CBIS will run for $0.2 to 0.3 next week.
Today target: $.085~0.10 with 30 million!
GO CBIS!!!
Golden February!!! FDA Application!
GO CBIS!
The new updated website is more formal toward FDA application, isn`t it?
GO CBIS
CBIS still talks about Phytiva.
What happened to Phytiva? Who physically owns Phytiva?
Great update!
Definitely agree with you!
GO CBIS!
what happens?
It is too late to CBIS! Not Real!
we will see its FDA application soon!
That is not the real situation!
CBIS can submit its FDA application at any time until CBIS gets enough primary data with proper management!
Financial revenue is not big issue, and can be easily solved!
GO CBIS!
Nobody can block CBIS FDA application!
CBIS will submit FDA application!
I do not think so. CBIS will present its great results!
So CBIS will definitely present its positive results from cancer treatment.
That will be great! A good opportunity for the FDA application!
CBIS will soar in the next few weeks!
GO CBIS!
CS-TATI-1 and CS-S/BCC-1
Although Federal laws do currently have some influence on the medicines from Marijuana products, I do not think that will block the process of CBIS FDA application, IMO.
The problems are what the real effects for cancer treatment are and how CBIS develops its products of CS-TATI-1 and CS-S/BCC-1. It looks like that CBIS is following the steps for the FDA application according to its consultants, does not it? But shareholders need solid news for that. The financial revenue and outline for the FDA application: Divy and file, respectively. Again, IMO.
The financial revenue is easily solved by the Divy as CBIS claimed before. Releasing the solid outline will speed both FDA application and financial revenue.